Bridgebio Pharma, Inc.
BBIO
Revenue
154.18M
▲33.48M▲27.74%
3 Months ChangeAssets
936.03M
▼-62.23M▼-6.23%
3 Months ChangeLiabilities
3.01B
▲91.63M▲3.14%
3 Months ChangeFree Cash Flow
-199.24M
▲21.00M▲9.53%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-24
Form 8-K
ID: 0001743881-26-000008
2026-02-12
Form 8-K
ID: 0001140361-26-004995
2026-01-21
Form 8-K
ID: 0001140361-26-001843
2026-01-12
Form 8-K
ID: 0001140361-26-000971
2025-10-29
Form 10-Q
ID: 0001743881-25-000012
2025-10-29
Form 8-K
ID: 0001140361-25-039705
2025-10-29
Form 8-K
ID: 0001743881-25-000010
2025-10-27
Form 8-K
ID: 0001140361-25-039463
2025-08-05
Form 10-Q
ID: 0000950170-25-103192
2025-08-05
Form 8-K
ID: 0000950170-25-102985